The article discusses a European Union (EU)-wide project that used a simple blood test to discover a series of genetic variations which can increase an individual's risk of getting prostate, breast, or ovarian cancer; also discussed is th...
Scientists have found a new way to predict which patients with the blood cancer myeloma will benefit the most from a treatment often used to help keep the disease from coming back after a stem cell transplant. For people with certain high-risk genetic features in theircancer cells, the drug,...
byInstitute of Cancer Research Testing for genetic risk factors could improve treatment for myeloma - a cancer of the blood and bone marrow - by helping doctors identify patients at risk of developing more aggressive disease. New research, published in theJournal of Clinical Oncologytoday, found as...
These tests commonly evaluate markers of ancestry with little attention to personal or family history of cancer. Many DTC tests also provide a report of single nucleotide polymorphisms (SNPs) which are then analyzed in the secondary market for everything from cancer risk to food sensitivity to...
Blood type A and the A1 allele have been associated with increased ovarian cancer risk. With only two small studies published to date, evidence for an association between ABO blood type and ovarian cancer survival is limited. We conducted a retrospective cohort study of Tumor Registry confirmed ov...
Studies on the hematopoietic lineage have traditionally relied on transplantation methodology [7,54,55]. At the tip of cellular hierarchy are the 'long-term' bone marrowhematopoietic SCsthat can give rise to 'short-term' hematopoietic SCs that produce the entire blood lineage. Although both SC ty...
Whole blood Test type Accepted for the following test types: Diagnostic testing (panels and exome) Proactive health panels Parental/familial studies Pediatric microarray analysis Personalized cancer monitoring Specimen types Specimen types accepted:
All that could have been avoided had a simple test been done. The test examines a gene that encodes a liverenzymecalled dihydropyrimidinedehydrogenase(or DPD for short). The enzyme breaks down several common cancer drugs. Without it, toxic levels of the drugs build up in the body, sometimes...
easy to miss with techniques that capture clean-but-incomplete samples of cancer cells from patient blood by grabbing onto proteins on the cells' surfaces. Stem-like cells are on a spectrum between two more-typical cell types, which means that they don't display consistent protein markers. ...
Blood derived DNA samples were genotyped for 211,155 SNPs on a custom Illumina array (iCOGS) in 25 074 prostate cancer cases and 24 272 controls. Details of genotyping and quality control analysis can be found in previous publication (Eeles et al, 2013). analyses were therefore adjusted for...